Katz Barrett 4
4 · Viridian Therapeutics, Inc.\DE · Filed Feb 10, 2023
Insider Transaction Report
Form 4
Katz Barrett
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2023-02-08+108,000→ 108,000 totalExercise: $34.20Exp: 2033-02-08→ Common Stock (108,000 underlying)
Footnotes (1)
- [F1]The option vests in equal monthly installments through February 8, 2027, subject to the Reporting Person's continued service to Issuer through each vesting date.